Facebook, Inc. (NASDAQ:FB) [Trend Analysis] knocking active thrust in leading trading session, shares a gain of 0.81% to 136.54 with around 5.35 Million shares have changed hands in this session. Facebook (FB) declared that it has recorded 300 billion “Reactions” on posts and the “Love” reaction was used maximum times by its over 1.79 billion users, the company said on Saturday. On February 24 last year, Facebook enhanced conversations by implementing “Reactions” – a group of emojis that has “Love”, “Haha”, “Wow”, “Sad” and “Angry” emoticons – that joined the famous “Like” button.
“It’s been one year since we could do more than ‘Like’ a friend’s post, and in that time, there have been a total of 300 billion reactions on posts to date,” Facebook said in a statement. “We have also analysed and are now able to share the most commonly used reactions and the times/places they are used most, providing insight about how Facebook’s more than 1.8 billion users express themselves on Facebook and beyond, the social media giant added. The stock is going forward its fifty-two week low with 30.78% and lagging behind from its 52-week high price with -0.19%.
Similar, the positive performance for the quarter recorded as 11.50% and for the year was 25.33%, while the YTD performance remained at 17.72%. FB has Average True Range for 14 days of 1.74.
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) [Trend Analysis] Chugai Pharmaceutical reported that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration, for the anti-cancer agent, alectinib hydrochloride for the treatment of people with “anaplastic lymphoma kinase positive, advanced non-small cell lung cancer who have progressed on or those intolerant to crizotinib.” Shares of slightly up 0.10% to trade at $30.35.